10th March 2022 | Pharma Updates

Sanofi Receives CDSCO Approval to Study Dupilumab

The drug major has received a nod from a committee of the Central Drug Standard Control Organization to perform a study of Dupilumab, used to treat patients with moderate-to-severe asthma and atopic dermatitis.

Covovax Wins EUA for Kids Above 12 Years

SII’s Covovax is the fourth vaccine to get the DCGI’s nod for use among those below 18 years of age.

USFDA Clears Cionic’s lightweight leg-worn neural sleeve

The all-new wearable neural sleeve by Ionic uses electrical stimulation to help improve the gait of people suffering from mobility problems.

CFT8634 Receives Orphan Drug Designation for Sarcoma Treatment

C4 Therapeutics announced that US’s drug regulator has given orphan drug designation to CFT8634 for the treatment of patients with soft tissue sarcoma.

KELIX bio to Purchase Morocco-based Pharma Institute

KELIX bio is planning to accelerate the delivery of drugs across the continent. The acquisition is expected to complete in the first quarter of this year.

Valneva Closes Phase 3 Chikungunya Vaccine Study

The clinical study revealed that 96.3% of the participants scored a protective level of chikungunya virus-neutralizing antibodies after six months of dose administration.

Hanmi to Present High BP Drug

Amosartan is the first homegrown combination therapy to enter China’s blood pressure treatment market.

KSL Diagnostics gets NYSDOH approval for Covid test

The company has received conditional approval from the New York State Department of Health for the COVID Test.

Sense Biodetection Wins CE Mark for Covid Diagnostic Test

Veros Covid-19 provides fast and accurate results in 15 minutes using patient-friendly anterior nasal swabs.

Rampart IC Signs Deal with JLL

Rampart IC, a medical device company dealing in radiation shielding and orthopaedic protection, has inked an agreement with Japan Lifeline, securing distribution to Japan’s medical market.